BRIEF-Aegerion pharmaceuticals enters into agreement with Sarissa Capital

[ahlam1399]

BRIEF-Aegerion pharmaceuticals enters into agreement with Sarissa Capital
* Pursuant to amendment standstill period has been deemed terminated as of march 21, 2016


http://rc.feedsportal.com/r/247395560504/u/49/f/654213/c/35217/s/4e6f75d3/sc/13/rc/1/rc.img (http://rc.feedsportal.com/r/247395560504/u/49/f/654213/c/35217/s/4e6f75d3/sc/13/rc/1/rc.htm)

http://rc.feedsportal.com/r/247395560504/u/49/f/654213/c/35217/s/4e6f75d3/sc/13/rc/2/rc.img (http://rc.feedsportal.com/r/247395560504/u/49/f/654213/c/35217/s/4e6f75d3/sc/13/rc/2/rc.htm)

http://rc.feedsportal.com/r/247395560504/u/49/f/654213/c/35217/s/4e6f75d3/sc/13/rc/3/rc.img (http://rc.feedsportal.com/r/247395560504/u/49/f/654213/c/35217/s/4e6f75d3/sc/13/rc/3/rc.htm)

http://da.feedsportal.com/r/247395560504/u/49/f/654213/c/35217/s/4e6f75d3/sc/13/a2.img (http://da.feedsportal.com/r/247395560504/u/49/f/654213/c/35217/s/4e6f75d3/sc/13/a2.htm)
http://adchoice.feedsportal.com/r/247395560504/u/49/f/654213/c/35217/s/4e6f75d3/sc/13/ach.img (http://adchoice.feedsportal.com/r/247395560504/u/49/f/654213/c/35217/s/4e6f75d3/sc/13/ach.htm)http://pi.feedsportal.com/r/247395560504/u/49/f/654213/c/35217/s/4e6f75d3/sc/13/a2t.imghttp://pi2.feedsportal.com/r/247395560504/u/49/f/654213/c/35217/s/4e6f75d3/sc/13/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e6f75d3/sc/13/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=Eo8okS2MK8g:ZfpQdqWh5hE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=Eo8okS2MK8g:ZfpQdqWh5hE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=Eo8okS2MK8g:ZfpQdqWh5hE:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=Eo8okS2MK8g:ZfpQdqWh5hE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=Eo8okS2MK8g:ZfpQdqWh5hE:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/Eo8okS2MK8g